Endocan as a prognostic biomarker of triple-negative breast cancer

PURPOSE: Triple-negative breast cancer (TNBC) has aggressive characteristics and fewer treatment options than other subtypes. The purpose of this study was to explore prognostic biomarkers for TNBC that can be easily detected from the blood samples. METHODS: MDA-MB-231 and MDA-MB-231BR, a brain meta...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Cancer Res Treat
Main Authors: Sagara, Atsunobu, Igarashi, Katsuhide, Otsuka, Maky, Kodama, Akihiro, Yamashita, Mutsumi, Sugiura, Rei, Karasawa, Takeshi, Arakawa, Kazuhiko, Narita, Michiko, Kuzumaki, Naoko, Narita, Minoru, Kato, Yoshinori
Formato: Artigo
Idioma:Inglês
Publicado em: Springer US 2016
Assuntos:
Preclinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5225208/
https://ncbi.nlm.nih.gov/pubmed/27888420
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-016-4057-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados